Cardiology Wiki
Search
Ctrl
+
K
Cardiology Wiki
Search
Ctrl
+
K
wiki
concepts
AAV Gene Delivery
ACHD Anatomic–Physiologic (AP) Classification
ACMG Secondary Findings
Acute Limb Ischemia (ALI)
AHA/ACC Acute PE Clinical Categories (2026)
Adult Immunization in Cardiovascular Disease
Adverse Pregnancy Outcomes
Biological Therapies for Atrial Fibrillation
AF-CARE Framework
Antithrombotic Strategy in AF with Stable Coronary Artery Disease
AF Staging
AI-ECG Detection of LV Scar in HCM
AI in Cardio-Oncology
AL Amyloidosis — Staging and Risk Stratification
Alcoholic Cardiomyopathy
Aldosterone Synthase Inhibitors
Amiodarone-Induced Thyroid Disorders
Amiodarone Pulmonary Toxicity
Angiography-Based Coronary Physiology
ANGPTL3 Inhibition
Ankle-Brachial Index (ABI)
Antiarrhythmic Drugs
Aortic Regurgitation
Aortic Stenosis
APOC3 Inhibition
Arrhythmia in Pregnancy
Arrhythmogenic Cardiomyopathy (ACM)
ARVC Task Force Criteria (2010 Modified)
ASCVD Risk Assessment
Atherosclerosis Pathophysiology
Athlete's Heart
Atrial Cardiomyopathy
Atrial Failure
Atrial Myopathy in HCM
Atrial Septal Defect
Atrioventricular Block
Autonomic Dysfunction in Cancer
Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
Atrioventricular Reentrant Tachycardia (AVRT) and Accessory Pathways
Balloon Pulmonary Angioplasty (BPA)
Beta-Blocker Therapy After Myocardial Infarction
Bidirectional Ventricular Tachycardia
Biological Pacemaker
Blood Culture–Negative Endocarditis (BCNE)
Blood Pressure Target in Type 2 Diabetes
Brain-Heart Axis
Calcium Homeostasis in HCM
Calmodulinopathy
Complementary and Alternative Medicine in Heart Failure
Cancer-Associated Arrhythmia
Cancer-Associated VTE
Cancer Therapy-Related Cardiovascular Toxicity (CTR-CVT)
Cardiac Action Potential
Cardiac Amyloidosis — Multimodality Imaging
Cardiac Glycosides in HFrEF
Cardiac Output Measurement
Cardiac Rehabilitation in Heart Failure
Cardiac Rehabilitation
Cardiac Repolarization
Cardiac Resynchronization Therapy
Cardio-Obstetrics
Cardio-Oncology
Cardiogenetic Centers
Cardiogenic Shock
Cardiopulmonary Exercise Testing (CPET)
Cardiorenal Syndrome
Carotid Sinus Syndrome
Cascade Family Screening (ACM & HCM)
Catheter Ablation for Atrial Fibrillation
Calcific Aortic Valve Disease — Molecular Mechanisms
Cerebral Embolic Protection during TAVI
CETP Inhibitors
CHA2DS2-VA Score
Circadian Rhythm and Cardiac Electrophysiology
ClinGen Gene-Disease Validity Framework
Clonal Hematopoiesis
Chronic Limb-Threatening Ischemia (CLTI)
Colchicine in Cardiovascular Disease
Conduction Disorders in Young Adults
Conduction System Pacing
Constrictive Pericarditis
Constrictive Pericarditis vs Restrictive Cardiomyopathy
Coronary Microvascular Dysfunction
Coronary Vasospasm
CRISPR-Cas9 in Channelopathies
Cuffless Blood Pressure Monitoring
Danon Disease
DAPT Strategies in ACS and CCD
Desmosome (Cardiac)
Diuretic Resistance
Drug-Induced Arrhythmia
Direct-to-Consumer Genetic Testing (DTC-GT)
Dyslipidemia Management
Early-Onset Atrial Fibrillation
ECG Conduction Disturbances
ECG Lead Standards
ECG Ventricular Hypertrophy
Extracorporeal Life Support in Pulmonary Hypertension
ECPELLA
Eisenmenger Syndrome
Electrical Remodeling
Electrical Storm
Epicardial Adipose Tissue Arrhythmogenesis
Epigenetics of Cardiac Arrhythmia
Exercise and Sports Participation in HCM
Exercise Restriction in ARVC
Fabry Cardiomyopathy
Familial Hypercholesterolemia
Fascicular Blocks
Fascicular Ventricular Tachycardia
Fetal Arrhythmia
Final Common Pathway (Cardiomyopathy)
Fontan Circulation — Adult Management
Fractional Flow Reserve (FFR)
Gene Editing Risk-Benefit Framework
Gene Silencing Therapy
Genetic Testing in Atrial Fibrillation
Genetic Testing in Cardiomyopathy
GLP-1 Receptor Agonists
Gut Microbiome in Heart Failure
GWAS in Cardiac Genetics
Haploinsufficiency
HCM Risk-SCD (and HCM Risk-Kids)
Heart-Healthy Dietary Patterns
Heart Valve Centre
Heteroplasmy
HF-COPD Comorbidity
HFA-ICOS Cardiovascular Toxicity Risk Stratification
His Bundle Pacing
Hormonal Therapy Cardiovascular Risk
Hyperacute T-waves
Hypertension-Mediated Organ Damage
Hypertensive Disorders of Pregnancy
Hypertriglyceridemia Management
Intra-Aortic Balloon Pump (IABP)
Inappropriate Sinus Tachycardia (IST)
Incidental Cardiovascular Genetic Variants
Infective Endocarditis
Instantaneous Wave-Free Ratio (iFR)
Inter-Atrial Block
Intracardiac Shunts
Intracoronary Imaging-Guided PCI
Invasive Hemodynamic Monitoring in Cardiogenic Shock
Ion Channel Mutations
Ion Channel Remodeling in HCM
iPSC-Derived Cardiomyocytes
Iron Deficiency in Heart Failure
Late Gadolinium Enhancement (LGE)
LBBB Criteria
Left Atrial Strain
Left Bundle Branch Area Pacing
Left Cardiac Sympathetic Denervation
Life's Essential 8
Lipid Gene Therapy
Lipoprotein(a)
Long Noncoding RNA in CVD
LQTS Pregnancy Management
Lung Transplantation in Pulmonary Arterial Hypertension
LV Diastolic Function
Left Ventricular Outflow Tract Obstruction (LVOTO)
Marfan Syndrome
MEPPC (Multifocal Ectopic Premature Purkinje-Related Complexes)
Metabolic Syndrome
Mineralocorticoid Receptor Antagonists After Myocardial Infarction
MINOCA
Mitochondrial Cardiomyopathy
Mitral Stenosis
Modifier Genes
Multivessel PCI Timing in STEMI
Modified WHO Classification of Maternal Cardiovascular Risk
Myocardial Viability
NOAC Management in Atrial Fibrillation
Perioperative NOAC Management
Noncoding RNA in Cardiovascular Disease
NSTEMI Invasive Strategy in Elderly Patients
NuSH Therapies
Obesity Paradox
OMI/NOMI Paradigm
Orthostatic Hypotension
OSA Arrhythmogenic Substrate
OTVA ECG Localization
PAD Exercise Therapy
PAD Medical Therapy
PAH Risk Stratification
Paroxysmal AV Block
PCI Before TAVI (Coronary Revascularisation in TAVI Candidates)
PCSK9 Inhibitors
Pericardial Effusion and Cardiac Tamponade
Pericarditis
Perioperative Cardiovascular Assessment
Periprocedural CIED Management
Permanent Pacing Indications
Pharmacogenomics in Heart Failure
Pharmacological Provocation Testing
Phenotypic Approach to Cardiomyopathy
Polygenic Risk Score
Pompe Disease
Post-Stroke AF Monitoring
Potassium and Ventricular Arrhythmias
Postural Tachycardia Syndrome (POTS)
Precision Medicine in LQTS
Preeclampsia
Prepregnancy Cardiovascular Health
Primary Mitral Regurgitation
Pulmonary Artery Pulsatility Index
Pulmonary Hypertension
Pulsed-Field Ablation
PVC-Induced Cardiomyopathy
PVC Mapping and Ablation
Q-Wave Remodeling
Radiation Vasculopathy
Right Bundle Branch Block
Remote Patient Monitoring in Cardiovascular Medicine
Renal Denervation
Right Heart Catheterization
Right Ventricular Failure
RV–PA Coupling
Sarcomere Biology
SCAI Shock Classification
Schwartz Score
Secondary Mitral Regurgitation
Septal Reduction Therapy (SRT)
Sex Differences in Channelopathies
Sgarbossa Criteria
SGLT2 Inhibitors in Chronic Kidney Disease
Shanghai Score System
Sinus Node Dysfunction
Sleep-Disordered Breathing
Sports Cardiology and Shared Decision-Making
ST-T Changes
Structural Valve Deterioration
Subclinical Atrial Fibrillation (SCAF)
Sudden Cardiac Death
Suppression-and-Replacement (SupRep) Therapy
Supraventricular Tachycardia (SVT) Management
Syncope
Tachycardia-Induced Cardiomyopathy (TCM)
TAVI (Transcatheter Aortic Valve Implantation)
Temporary Mechanical Circulatory Support
Tetralogy of Fallot (Repaired) — Adult Management
Titin Isoform Switch
Titin Post-Translational Modifications (PTMs)
Torsades de Pointes
Tricuspid Regurgitation
TTR Stabilizer Therapy
VA Risk Stratification in Dilated Cardiomyopathy
Valvular Heart Disease
Genetic Variant Reclassification in Cardiovascular Disease
Vasoactive Agents in Cardiogenic Shock
Vasovagal Syncope (VVS)
Venous Thromboembolism — Anticoagulation
Visceral Adiposity and Ectopic Fat
VO2max (Maximal Oxygen Uptake)
VT Ablation in Ischemic Cardiomyopathy
Wellens Syndrome
Wide Complex Tachycardia
entities
Acute Coronary Syndrome
Aficamten
AL (Light Chain) Amyloidosis
Alirocumab
Arrhythmogenic Left Ventricular Cardiomyopathy (ALVC)
Amiodarone
Andersen-Tawil Syndrome (LQT7)
Anderson-Fabry Disease (AFD)
Aneurysm-Osteoarthritis Syndrome
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Atrial Fibrillation
Atrial Flutter
Transthyretin Amyloidosis (ATTR)
Bicuspid Aortic Valve
Brugada Syndrome
Cardiac Glycosides
CASQ2
Cardiac Contractility Modulation (CCM)
Chronic Coronary Disease
Chronic Obstructive Pulmonary Disease (COPD)
CORIN
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Cardiac Resynchronization Therapy (CRT)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Dilated Cardiomyopathy (DCM)
DES (Desmin)
Dronedarone
DSC2 (Desmocollin-2)
DSG2 (Desmoglein-2)
DSP (Desmoplakin)
Early Repolarization Syndrome
Evinacumab
Evolocumab
Fabry Disease
FBN1
Finerenone (Kerendia)
Flecainide
FLNC (Filamin-C)
Frailty in Cardiovascular Disease
Hypertrophic Cardiomyopathy (HCM)
Heart Failure
Heart Failure with Preserved Ejection Fraction (HFpEF)
HFrEF — Heart Failure with Reduced Ejection Fraction
Hypertension
Implantable Cardioverter-Defibrillator (ICD)
Idiopathic Ventricular Fibrillation
Inclisiran
Ischemic Stroke
JUP (Plakoglobin) — Naxos Disease
KCNH2 (hERG)
KCNJ2 (Kir2.1)
KCNQ1
Left Atrial Appendage Occlusion (LAAO)
Left Main Coronary Disease
Levosimendan
LMNA (Lamin A/C)
Loeys-Dietz Syndrome
Long QT Syndrome
MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease)
Maternal Health Disparities
Mavacamten
Mitral Valve Prolapse
MYBPC3 (Cardiac Myosin Binding Protein C)
MYH6 (Alpha-Myosin Heavy Chain)
MYH7 (Beta-Myosin Heavy Chain)
Non-Dilated Left Ventricular Cardiomyopathy (NDLVC)
Nexiguran Ziclumeran (Nex-z / NTLA-2001)
NOS1AP
Obesity
Obstructive Sleep Apnea
Olezarsen
Omecamtiv Mecarbil
Patisiran
Peripartum Cardiomyopathy
Peripheral Artery Disease
PKP2 (Plakophilin-2)
PLN (Phospholamban)
PMCardio Queen of Hearts
PRKAG2 Cardiac Syndrome
Pulmonary Embolism
Restrictive Cardiomyopathy (RCM)
Rheumatic Heart Disease
RYR2
Subcutaneous ICD (S-ICD)
Sacubitril–Valsartan (ARNI)
SCN5A
Semaglutide
Short QT Syndrome
Sotatercept
Takotsubo Cardiomyopathy
Tirzepatide
TMEM43
TTN (Titin)
Type 2 Diabetes
Vectorcardiography
Vericiguat
Vutrisiran (AMVUTTRA)
sources
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
AAV9-Mediated Gene Therapy for Infantile-Onset Pompe's Disease
AAV-mediated gene therapy for cardiac tachyarrhythmia: A systematic review and meta-analysis
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload (ADVOR)
2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management
2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy (ATTRibute-CM)
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
2024 ESC Guidelines for the Management of Atrial Fibrillation
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy (MAPLE-HCM)
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (SEQUOIA-HCM)
Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association
2026 AHA/ASA Guideline for Early Management of Acute Ischemic Stroke
Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association
Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association
Amiodarone: A Comprehensive Guide for Clinicians
Amiodarone Pulmonary Toxicity
Amiodarone: Review of Pulmonary Effects and Toxicity
Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders
ANGPTL3 Inhibition, Dyslipidemia, and Cardiovascular Diseases
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation (ARTESIA)
Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)
PARADIGM-HF: Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology
Importance of Diastolic Function for the Prediction of Arrhythmic Death (Pezawas et al.)
Cardiac arrhythmias and genetics – current stage
2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke
2023 HRS Expert Consensus Statement on the Management of Arrhythmias During Pregnancy
Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years
Current concept of transcatheter closure of atrial septal defect in adults
Atrial septal defect in adulthood: a new paradigm for congenital heart disease
Unresolved questions in atrial septal defect pathophysiology: Shunt dynamics, exercise physiology, and pulmonary vascular disease risk
Atrial septal defects
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension (BaxHTN)
Beta-Blocker Interruption or Continuation after Myocardial Infarction — ABYSS Trial
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction (REDUCE-AMI)
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction (SMART-DECISION)
Blood Culture–Negative Endocarditis: A Scientific Statement From the American Heart Association
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk
Systematic Review of Biological Therapies for Atrial Fibrillation
Efficacy and Safety of Bisoprolol in Patients with COPD: A Systematic Review and Meta-Analysis
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD)
Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay
Brugada Syndrome (State-of-the-Art Review)
Catheter Ablation for Atrial Fibrillation: Indications and Future Perspective
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation (CASTLE-HTx)
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes
2025 ACC Concise Clinical Guidance: CV Adverse Effects of Targeted Oncology Therapies (BTK, ICI, VEGF Inhibitors)
Cardiac glycosides in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis
Core Components of Cardiac Rehabilitation Programs: 2024 Update
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
2022 ESC Guidelines on Cardio-Oncology
Cardio-Oncology: Vascular and Metabolic Perspectives — AHA Scientific Statement 2019
2025 ACC Concise Clinical Guidance: Evaluation and Management of Cardiogenic Shock
Contemporary Management of Cardiogenic Shock: A Scientific Statement from the American Heart Association
Cardiogenic Shock (NEJM 2026 Review)
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies — AHA Scientific Statement 2019
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism (HI-PEITHO)
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation (BHF PROTECT-TAVI)
Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association
Cardiac Channelopathies: Clinical Diagnosis and Promising Therapeutics
Circadian Influences on Sudden Cardiac Death and Cardiac Electrophysiology
ClinGen Curation Activity Summary Report 2026-05-09
Methods in pharmacology: measurement of cardiac output
Cardiac Output Monitoring – Invasive and Noninvasive
Cardiac Output Monitoring Using Indicator-Dilution Techniques: Basics, Limits, and Perspectives
Colchicine in Acute Myocardial Infarction (CLEAR Trial)
Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction (MULTISTARS AMI)
Cardiac Conduction Disorders Due to Acquired or Genetic Causes in Young Adults: A Review of the Current Literature
Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association
Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction
Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis
Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies
Cardiac Rehabilitation for Patients With Heart Failure
Part 1—Cardiac Rehabilitation After an Acute Myocardial Infarction: Four Phases of the Programme—Where Do We Stand?
Cardiac Rehabilitation — Challenges, Advances, and the Road Ahead
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure (CARE-HF)
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure (RAFT Long-Term)
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events (MADIT-CRT)
EHRA Clinical Consensus Statement on Conduction System Pacing Implantation (2023)
Cardiac Conduction System Pacing: A Comprehensive Update
Cuffless Devices for the Measurement of Blood Pressure: A Scientific Statement From the American Heart Association
Cardiovascular Considerations in Caring for Pregnant Patients
2018 ESC Guidelines for the Management of Cardiovascular Diseases during Pregnancy
Dapagliflozin in Patients with Chronic Kidney Disease (DAPA-CKD)
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (DELIVER)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
DASH vs. Mediterranean Diet on a Salt Restriction Background in Adults with High Normal Blood Pressure or Grade 1 Hypertension: A Randomized Controlled Trial
Dietary Management of Heart Failure: DASH Diet and Precision Nutrition Perspectives
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
Dilated Cardiomyopathy and Precision Medicine — Heart Failure Reviews 2022
2026 AHA Dietary Guidance to Improve Cardiovascular Health
Dietary Strategies for Metabolic Syndrome: A Comprehensive Review
Digitoxin in Heart Failure with Reduced Ejection Fraction (DIGIT-HF) — Bavendiek, Bauersachs et al., NEJM 2025
Dronedarone
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (EAST-AFNET 4)
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part III: Intraventricular Conduction Disturbances
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part VI: Acute Ischemia/Infarction
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the ECG — Part IV: The ST Segment, T and U Waves, and the QT Interval
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part I: The Electrocardiogram and Its Technology
Recommendations for the Evaluation of LV Diastolic Function by Echocardiography and for HFpEF Diagnosis: An Update from the ASE (2025)
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes (NOAH-AFNET 6)
Empagliflozin after Acute Myocardial Infarction (EMPACT-MI)
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease (EMPA-KIDNEY Post-Trial)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction (EMPEROR-Preserved)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (EMPEROR-Reduced)
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes
Early-onset atrial fibrillation without structural heart disease: lifestyle and hereditary risk factors
Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue
2023 ESC Guidelines for the Management of Cardiomyopathies
Anderson–Fabry Disease Management: Role of the Cardiologist
Fabry Disease Cardiomyopathy: A State-of-the-Art Review
Failure of standard contemporary STEMI ECG criteria to identify acute LAD occlusion
Ferric Carboxymaltose in Heart Failure with Iron Deficiency (HEART-FID)
FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF)
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
Gene Editing Therapy in Cardiovascular Disease: 2026 ACC Scientific Statement
Gene editing for inherited cardiac conditions: A new frontier in cardiology
Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications
Clinical Genetic Testing for Atrial Fibrillation: Are We There Yet?
Genetically based atrial fibrillation: Current considerations for diagnosis and management
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
Genetic testing in early-onset atrial fibrillation
Genetic Testing for Inherited Cardiovascular Diseases — AHA Scientific Statement 2020
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing
The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease
Actionable Genotypes and Their Association with Life Span in Iceland
The Utility of Genome-Wide Association Studies in Inherited Arrhythmias and Cardiomyopathies
Hyperacute T Waves Are Specific for Occlusion Myocardial Infarction, Even Without Diagnostic ST-Segment Elevation
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
Hemiblocks Revisited
Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Hemodynamics in the Cardiac Catheterization Laboratory of the 21st Century
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heart failure and chronic obstructive pulmonary disease. A combination not to be underestimated
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association
2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System
2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
Intra-Aortic Balloon Counterpulsation
ACC/AHA/HRS 2025 Appropriate Use Criteria for ICD, CRT, and Pacing
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure (SCD-HeFT) — Bardy et al., NEJM 2005
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction (MADIT-II)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure (DANISH Trial)
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy (DEFINITE)
2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal ICD Programming and Testing
Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction (iMODERN)
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis — Part 2
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis — Part 1
Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart Association
State of the Art: Imaging for Myocardial Viability — AHA Scientific Statement
2025 ACC Concise Clinical Guidance: Adult Immunizations as Part of Cardiovascular Care
Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease: A Scientific Statement From the American Heart Association
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
The Inherited Basis of Coronary Artery Disease
Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease
Intravascular Ultrasound–Guided or Angiography-Guided Complex High-Risk PCI
IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease
Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation (CHAMPION-AF)
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation (CLOSURE-AF)
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation (OPTION Trial)
Left bundle branch block: from cardiac mechanics to clinical and diagnostic challenges
Re-evaluating the electro-vectorcardiographic criteria for left bundle branch block
Systemic Light Chain Amyloidosis
Levosimendan: New Drug Profile
Levosimendan, a Promising Pharmacotherapy in Cardiogenic Shock: A Comprehensive Review
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry
Use of Levosimendan in Patients with Advanced Heart Failure: An Update
2026 ACC/AHA Guideline on the Management of Dyslipidemia
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension (ADVANCE-HTN)
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for ASCVD — AHA Scientific Statement 2021
A Test in Context: Lipoprotein(a) — Diagnosis, Prognosis, Controversies, and Emerging Therapies
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
Differentiating the QRS Morphology of Posterior Fascicular Ventricular Tachycardia From Right Bundle Branch Block and Left Anterior Hemiblock Aberrancy
Congenital Long QT Syndrome
Long QT Syndrome
Long QT Syndrome Management during and after Pregnancy
Explainable AI identifies and localizes LV scar in HCM using 12-Lead ECG
Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes
Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome
The revised Ghent nosology for the Marfan syndrome
Marfan's syndrome
Marfan syndrome. Part 1: pathophysiology and diagnosis
Metabolic Dysfunction–Associated Steatotic Liver Disease
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (ODYSSEY-HCM)
Mechanical Circulatory Support in Cardiogenic Shock
Mechanical Circulatory Support in Cardiogenic Shock
Cardiac Transmembrane Ion Channels and Action Potentials: Cellular Physiology and Arrhythmogenic Behavior
Metoprolol for the Prevention of Acute Exacerbations of COPD (BLOCK COPD)
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease
Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association
Modifier Genes for Sudden Cardiac Death
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure (RALES) — Pitt et al., NEJM 1999
Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation (COAPT 5-Year)
Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation (MATTERHORN)
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation (RESHAPE-HF2)
Cardiac Myosin-Binding Protein C (MYBPC3) in Cardiac Pathophysiology
Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3 and MYH7-Mediated Hypertrophic Cardiomyopathy
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
2018 EHRA Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism (COBRRA)
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia — ESSENCE–TIMI 73b
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure (GALACTIC-HF)
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes (SOUL)
Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review
Pulmonary Artery Pulsatility Index: Physiological Basis and Clinical Application
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis (APOLLO-B)
Paroxysmal Atrioventricular Block
Invasive Treatment Strategy for Older Patients with Myocardial Infarction
REVIVED-BCIS2: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation (NOTION-3)
PCSK9 inhibitors: clinical evidence and implementation
Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
2025 ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association
Peripartum Cardiomyopathy
Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation (ADVENT)
Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation — SINGLE SHOT CHAMPION
The Diagnostic Role of Pharmacological Provocation Testing in Cardiac Electrophysiology — EHRA Consensus 2025
2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension
Multidomain Rehabilitation for Older Patients with Myocardial Infarction (PIpELINe)
Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias (POTCAST)
Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance
2015 HRS Expert Consensus Statement on POTS, IST, and Vasovagal Syncope
Precision therapy in congenital long QT syndrome
Optimizing Prepregnancy Cardiovascular Health to Improve Outcomes in Pregnant and Postpartum Individuals and Offspring: A Scientific Statement From the American Heart Association
Mapping and Ablation of Premature Ventricular Complexes
2024 ACC/AHA Guideline for the Management of Lower Extremity Peripheral Artery Disease
Electrocardiographic Q-Wave 'Remodeling' in Reperfused ST-Segment Elevation Myocardial Infarction: Validation Study With CMR
Right Bundle Branch Block: Current Considerations
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Cardiac Repolarization in Health and Disease
Right heart catheterization in heart failure: indications, interpretation, and pitfalls
Practical Guidance for Hemodynamic Assessment by Right Heart Catheterization in Management of Heart Failure
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association
Right Ventricular Failure
Differentiating Right- and Left-Sided Outflow Tract Ventricular Arrhythmias: Classical ECG Signatures and Prediction Algorithms
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data
Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy
Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications — AHA Scientific Statement
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity (STEP-HFpEF)
Estimation of intracardiac shunts in young children with a novel indicator dilution technology
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis (HYPERION)
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death (ZENITH)
Routine Spironolactone in Acute Myocardial Infarction — CLEAR (NEJM 2025)
Spironolactone for Heart Failure with Preserved Ejection Fraction (TOPCAT)
Electrophysiological Mechanisms of ST Segment and T‑Wave Changes: Insights into Ischemia, Conduction Delay, Hypertrophy, and Electrolyte Disturbance
Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap — AHA Scientific Statement 2019
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia
Simplified Integrated Clinical and Electrocardiographic Algorithm for Differentiation of Wide QRS Complex Tachycardia — The Basel Algorithm
Diagnostic criteria of broad QRS complex tachycardia: decades of evolution
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy
Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis (EARLY TAVR)
Transcatheter or Surgical Treatment of Aortic-Valve Stenosis — DEDICATE-DZHK6
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years (PARTNER 3)
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
Tricuspid Regurgitation (NEJM 2023)
Titin (TTN): from molecule to modifications, mechanics, and medical significance
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation (TRISCEND II)
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association
Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE Pivotal)
Predicting Sustained Ventricular Arrhythmias in Dilated Cardiomyopathy: A Meta-Analysis and Systematic Review
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Review of Processing Pathological Vectorcardiographic Records for the Detection of Heart Disease
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction (VICTORIA)
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
Angiography-Based Physiology to Guide Coronary Revascularization (FAST III)
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association
VO2,max: what do we know, and what do we still need to know?
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia (VANISH2)
A New Approach to the Differential Diagnosis of a Regular Tachycardia With a Wide QRS Complex
Simple Electrocardiographic Criteria for Rapid Identification of Wide QRS Complex Tachycardia: the new Limb Lead Algorithm
Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (HELIOS-B)
Conceptual and Literature Basis for Wide Complex Tachycardia and Baseline ECG Comparison
Wide Complex Tachycardia Differentiation: A Reappraisal of the State-of-the-Art
Wearable Digital Health Technologies for Monitoring in Cardiovascular Medicine
2025 ACC Concise Clinical Guidance: Medical Weight Management for Optimization of Cardiovascular Health
Source Index
Wiki Index
Arrhythmia index
Cardiomyopathy index
Drug index
ECG & Physiology index
Fellow study
Genetics index
Cardiology Wiki Master Index
Enter your search text in the box above
Select a result to preview
Cardiology Wiki (Genetics)
Overview
ClinGEN
clingen-summary-2026-05-09
ClinGEN validity
ClinGen-Gene-Disease-Validity
Genetic test in CMP
concepts/Genetic-Testing-in-Cardiomyopathy
Genetic test in AF
concepts/Genetic-Testing-in-AF
Modifier genes
Modifier-Genes
GWAS
GWAS-Cardiac-Genetics
VUS
Incidental-Cardiovascular-Variants
Cascade Family screening
Cascade-Family-Screening
DTC genetic testing
DTC-Genetic-Testing
AAV Gene Delivery
AAV-Gene-Delivery
SupRep Therapy
SupRep-Therapy
Gene Silencing Therapy
Gene-Silencing-Therapy
GET
Gene-Editing-Risk-Benefit-Framework
Channelopathy
LQTS
Long-QT-Syndrome
SQTS
Short-QT-Syndrome
Brugada Syndrome
Brugada-Syndrome
CPVT
CPVT
ERS
Early-Repolarization-Syndrome
IVF
Idiopathic-Ventricular-Fibrillation
CRISPR-Cas9
CRISPR-Cas9-in-Channelopathies
LQTS
KCNQ1
KCNQ1
KCNH2
KCNH2
CALM
Calmodulinopathy
SCN5A
SCN5A
CPVT
RYR2
RYR2
CASQ2
CASQ2
Cardiomyopathies
ARVC
ARVC
ACM
Arrhythmogenic-Cardiomyopathy
HCM
HCM
DCM
DCM
ARVC
PKP2
PKP2
DSC2
DSC2
DSG2
DSG2
DSP
DSP
TMEM43
TMEM43
DCM
TTN
TTN
LMNA
LMNA
FLNC
FLNC
DES
DES
HCM
MYBPC3
MYBPC3
MYH7
MYH7
PLN
PLN
Dyslipidemia
PCSK9
PCSK9-Inhibitors
ANGPTL3
ANGPTL3-Inhibition
APOC3
APOC3-Inhibition
Gene therapy
Lipid-Gene-Therapy
Marfan syndrome
Marfan-Syndrome
FBN1
FBN1
Misc
Desmosome
Desmosome
Haploinsufficiency
Haploinsufficiency
Titin PTM
Titin-PTMs
Titin isoform switch
Titin-Isoform-Switch
Noncoding RNA in CVD
Noncoding-RNA-in-CVD
Pharmacogenomics in HF
Pharmacogenomics-in-HF
CORIN
CORIN
PRKAG2
PRKAG2-Cardiac-Syndrome